Zak, Mark <br/><br/>
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  06 2019 
 - 1522-1531 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2019.04.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dermatitis, Atopic--genetics<br/>Humans<br/>Interleukin-13--metabolism<br/>Janus Kinase 1--antagonists & inhibitors<br/>Janus Kinase 2--antagonists & inhibitors<br/>Signal Transduction